April 9, 2024– CriticalPoint is pleased to announce that it served as the exclusive financial advisor to Alcanza Clinical Research, a portfolio company of Martis Capital, on its acquisition of Innovation Medical Research Center (“Innovation”).
Located in Palmetto Bay, Fla., Innovation conducts Phase I to Phase IV clinical trials in key therapeutic areas such as cardiology, dermatology, endocrinology, gastroenterology, infectious disease, internal medicine, nephrology, neurology, psychiatry, rheumatology, and women’s health.
About Alcanza Clinical Research
Alcanza is an integrated network of research facilities dedicated to reducing barriers to clinical research participation, especially in underrepresented patient populations. The network includes 24 dedicated research units and 7 additional sites integrated within specialty clinics. These facilities are strategically located across the Southeast, Northeast, and Midwest regions of the United States and Puerto Rico. Alcanza supports studies that span all trial phases and major therapeutic areas. Please visit www.AlcanzaClinical.com to learn more.
About Martis Capital
Based in Washington, DC, Miami, FL, and San Francisco, CA, Martis Capital is a team of investment professionals who share a passion for helping build companies that aim to improve the quality of care and to address the complex challenges facing the healthcare industry today. Since 2011, Martis Capital has raised more than $2.2 billion from a global base of institutional clients to invest in the middle-market North American healthcare sector.
CriticalPoint served as the exclusive financial advisor to Alcanza Clinical Research in connection with the transaction. The transaction demonstrates CriticalPoint’s expertise in middle market advisory and commitment to act as a trusted advisor with proven abilities to deliver for its clients.
If you would like more information about CriticalPoint or have questions regarding this transaction, please contact:
Willy Doremus
Vice President
Direct: (424) 206-5064
[email protected]
Shawn Wada
Business Development
Direct: (424) 374-1950
[email protected]
About CriticalPoint
Headquartered in Los Angeles, CriticalPoint is a leading full-service financial M&A firm that uniquely combines the best of investment banking, private capital, and valuation service offerings. CriticalPoint executes, sources, and invests in deals across a wide variety of industries for the traditionally underserved middle market. Since our founding in 2012, our mission has been to serve the needs of owners, entrepreneurs, management teams, and stakeholders with our experience, knowledge, and expert judgment, to help them realize their companies’ greatest potential. From our deep-rooted foundation in private equity and investment banking, and our devotion to deal origination and business development, combined with being entrepreneurs at heart, we believe we are differentiated and well positioned to help companies wherever they are in their life cycle.
Messers. Doremus and Wada are Registered Representatives of, and Securities Products are offered through CriticalPoint Partners, LLC Member FINRA, SIPC. Any testimonial or endorsement may not be representative of the experience of other customers and is no guarantee of future performance or success.
